Staar Surgical Co (NASDAQ:STAA) has a beta value of 0.66 and has seen 1.23 million shares traded in the last trading session. The company, currently valued at $1.00B, closed the last trade at $20.27 per share which meant it gained $0.85 on the day or 4.38% during that session. The STAA stock price is -145.98% off its 52-week high price of $49.86 and 33.4% above the 52-week low of $13.50.
The consensus among analysts is that Staar Surgical Co (STAA) is Buy stock at the moment, with a recommendation rating of 2.71. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 13 have rated it as a Hold, with 11 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.6.
Staar Surgical Co (NASDAQ:STAA) trade information
Sporting 4.38% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the STAA stock price touched $20.27 or saw a rise of 4.16%. Year-to-date, Staar Surgical Co shares have moved -16.55%, while the 5-day performance has seen it change 6.80%. Over the past 30 days, the shares of Staar Surgical Co (NASDAQ:STAA) have changed 30.19%.
Wall Street analysts have a consensus price target for the stock at $48, which means that the shares’ value could jump 57.77% from current levels. The projected low price target is $45.03 while the price target rests at a high of $85.0. In that case, then, we find that the current price level is -319.34% off the targeted high while a plunge would see the stock gain -122.15% from current levels.
Staar Surgical Co (STAA) estimates and forecasts
The company’s shares have lost -34.32% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -18.08%.
8 analysts offering their estimates for the company have set an average revenue estimate of 40.71M for the current quarter. 8 have an estimated revenue figure of 91.58M for the next ending quarter. Year-ago sales stood 99M and 88.59M respectively for this quarter and the next, and analysts expect sales will shrink by -58.88% for the current quarter and -18.08% for the next.
Earnings growth for 2025 is a modest -476.30% while over the next 5 years, the company’s earnings are expected to increase by 20.94%.
STAA Dividends
Staar Surgical Co is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Staar Surgical Co (NASDAQ:STAA)’s Major holders
The top two institutional holders are BROADWOOD CAPITAL INC with over 10.77 million shares worth more than $512.68 million. As of 2024-06-30, BROADWOOD CAPITAL INC held 21.9196% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 7.49 million shares as of 2024-06-30. The firm’s total holdings are worth over $356.54 million and represent 15.2438% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 6.15% shares in the company for having 3.05 shares of worth $61.73 million while later fund manager owns 1.55 shares of worth $31.38 million as of Dec 31, 2024 , which makes it owner of about 3.13% of company’s outstanding stock.
